Ares Commercial Real Estate Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Ares Commercial Real Estate Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.83M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $69.65M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $92.93M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $106.85M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $102.07M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $82.70M | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $13.49M | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $13.15M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $13.32M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $12.25M | Feb 20, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($902.0K) | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | ($34.99M) | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | ($38.87M) | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $29.79M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $60.46M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $21.84M | Feb 15, 2023 |
| FY2019 | Dec 31, 2019 | $9.66M | Feb 20, 2020 |
| FY2019 | Sep 30, 2019 | $9.03M | Feb 20, 2020 |
| FY2019 | Jun 30, 2019 | $9.76M | Feb 20, 2020 |
| FY2019 | Mar 31, 2019 | $8.54M | Feb 20, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.35M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $35.55M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $46.79M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $57.16M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $48.35M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $31.76M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $32.45M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $39.22M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $31.28M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | ($4.49M) | Feb 21, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $823.0K | Mar 5, 2015 |
| FY2014 | Dec 31, 2013 | $41.0K | Mar 5, 2015 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.62B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.75B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $2.28B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $2.52B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.63B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.93B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.78B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $1.60B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $1.77B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $1.37B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.11B | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $1.21B | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | $1.65B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.78B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $1.95B | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $1.46B | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $1.36B | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $1.18B | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $1.35B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $944.03M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $509.57M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $540.13M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $625.85M | Feb 10, 2026 |
| FY2025 | Dec 31, 2022 | $747.54M | Feb 10, 2026 |
| FY2024 | Dec 31, 2021 | $678.63M | Feb 12, 2025 |
| FY2021 | Dec 31, 2020 | $473.02M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $426.34M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $425.59M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | $419.17M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $419.03M | Mar 1, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($311.79M) | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | ($277.36M) | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | ($187.02M) | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | ($73.33M) | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | ($28.63M) | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | ($25.12M) | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | $2.44M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | $3.57M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | ($1.75M) | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | ($1.31M) | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $29.29M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $63.80M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $110.46M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $141.28M | Feb 12, 2025 |
| FY2022 | Dec 31, 2021 | $50.62M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | $74.78M | Feb 15, 2022 |
| FY2021 | Dec 31, 2019 | $5.26M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $11.09M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $28.34M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $47.27M | Feb 21, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $948.18M | Feb 10, 2026 |
| FY2024 | Dec 31, 2024 | $718.47M | Feb 12, 2025 |
| FY2023 | Dec 31, 2023 | $894.82M | Feb 22, 2024 |
| FY2022 | Dec 31, 2022 | $960.23M | Feb 15, 2023 |
| FY2021 | Dec 31, 2021 | $1.04B | Feb 15, 2022 |
| FY2020 | Dec 31, 2020 | $928.67M | Feb 18, 2021 |
| FY2019 | Dec 31, 2019 | $894.74M | Feb 20, 2020 |
| FY2018 | Dec 31, 2018 | $887.97M | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | $1.07B | Mar 1, 2018 |
| FY2016 | Dec 31, 2016 | $935.71M | Mar 7, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 1 | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | 0 | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | 0 | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 7, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | 1 | Feb 21, 2019 |
| FY2017 | Dec 31, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Sep 30, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Jun 30, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Mar 31, 2017 | 0 | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | 0 | Mar 1, 2018 |
| FY2017 | Sep 30, 2016 | 0 | Mar 1, 2018 |
| FY2017 | Jun 30, 2016 | 0 | Mar 1, 2018 |
| FY2017 | Mar 31, 2016 | 0 | Mar 1, 2018 |
| FY2016 | Dec 31, 2015 | 0 | Mar 7, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 55.03M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | 54.54M | Feb 10, 2026 |
| FY2024 | Dec 31, 2023 | 54.15M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 54.44M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 47.14M | Feb 15, 2023 |
| FY2021 | Dec 31, 2020 | 33.44M | Feb 15, 2022 |
| FY2020 | Dec 31, 2019 | 28.87M | Feb 18, 2021 |
| FY2019 | Dec 31, 2018 | 28.76M | Feb 20, 2020 |
| FY2018 | Dec 31, 2017 | 28.60M | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | 28.61M | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $39.01M | Feb 10, 2026 |
| FY2025 | Dec 31, 2024 | $59.64M | Feb 10, 2026 |
| FY2025 | Dec 31, 2023 | $75.95M | Feb 10, 2026 |
| FY2024 | Dec 31, 2022 | $71.81M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $58.42M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $42.77M | Feb 15, 2023 |
| FY2021 | Dec 31, 2019 | $37.49M | Feb 15, 2022 |
| FY2020 | Dec 31, 2018 | $32.09M | Feb 18, 2021 |
| FY2019 | Dec 31, 2017 | $30.53M | Feb 20, 2020 |
| FY2018 | Dec 31, 2016 | $29.40M | Feb 21, 2019 |